Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP)
Authors:
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 127 (4) , 247-254
Abstract
Seven male Japanese children with chronic granulomatous disease were given sulfamethoxazole-trimethoprim (SMX-TMP) for recurrent pyogenic infections, most of which had proved difficult to control with other antibiotics. With continuous treatment the children remained free of infections severe enough to necessitate hospitalization, except on one occasion. Serious complications, including hematological disorders, never occurred during therapy and there were no changes in leukocyte function during therapy. These results indicate that SMX-TMP should be considered in the treatment of bacterial infections associated with chronic granulomatous disease.Keywords
This publication has 26 references indexed in Scilit:
- Pancytopenia in an infant associated with sulfamethoxazole-trimethoprim therapyThe Journal of Pediatrics, 1976
- Agents responsible for infection in chronic granulomatous disease of childhoodThe Journal of Pediatrics, 1975
- The Effect of Co-Trimoxazole on Antitoxin Response to Tetanus ToxoidChemotherapy, 1975
- Nocardiosis in a child with chronic granulomatous diseaseThe Journal of Pediatrics, 1973
- Chronic granulomatous disease of childhood with onset of symptoms at age 11 yearsThe Journal of Pediatrics, 1972
- Trimethoprim and Sulphamethoxazole in Typhoid Fever in ChildrenBMJ, 1971
- Drug NeutropeniaBMJ, 1970
- Chronic Granulomatous Disease: Quantitative Clinicopathological RelationshipsArchives of Disease in Childhood, 1970
- Agranulocytosis after trimethoprim and sulphamethoxazole.BMJ, 1969
- Trimethoprim and Sulphamethoxazole in TyphoidBMJ, 1968